Virtus Biotech Clinical Trials ETF (BBC) price, chart and fund profile
Price chart
Fund profile
BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials.
- Issuer
- Virtus Investment Advisers, LLC
- Industry
- Healthcare
- Inception
- Dec 16, 2014
- Assets under management
- $50.6M
- Expense ratio
- 0.65%
- Net asset value
- $53.22
- NAV as of
- Aug 28, 2026
- Leverage
- 1×
- Fund page
- www.virtus.com↗
Frequently asked questions
What is Virtus Biotech Clinical Trials ETF (BBC)?
BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials.
What is BBC's expense ratio?
Virtus Biotech Clinical Trials ETF charges an annual expense ratio of 0.65%. The fund is issued by Virtus Investment Advisers, LLC.
How large is BBC?
Virtus Biotech Clinical Trials ETF manages $50.6M in assets and has traded since Dec 16, 2014.
How do I buy shares of Virtus Biotech Clinical Trials ETF (BBC)?
BBC trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.